New VR grant to Ingrid Glimelius
She has been awarded a project grant in the Swedish Research Council’s call for proposals for planning a future clinical study in therapy research.
The grant amounts to SEK 1.1 million and will be used for the SOPHIA study, which concerns prophylactic human immunoglobulin treatment in aggressive B-cell lymphoma.
More information: